Results 211 to 220 of about 602,267 (275)

Real‐world outcomes of daratumumab, bortezomib, thalidomide and dexamethasone (Dara‐VTd) induction and lenalidomide maintenance in transplant‐eligible multiple myeloma

open access: yes
British Journal of Haematology, Volume 209, Issue 5, Page 2321-2325, November 2026.
Edvan Q. Crusoé   +20 more
wiley   +1 more source

Pirtobrutinib in Richter syndrome: Outcomes from the named patient programme in Italy

open access: yes
British Journal of Haematology, Volume 209, Issue 5, Page 2302-2306, November 2026.
Isacco Ferrarini   +19 more
wiley   +1 more source

A prospective, phase IV study of ixazomib, pomalidomide and dexamethasone in patients with relapsed or refractory multiple myeloma

open access: yes
British Journal of Haematology, Volume 209, Issue 5, Page 2316-2320, November 2026.
Runfeng Zhang   +15 more
wiley   +1 more source

Pregnancy in Patients With Cyclic Neutropenia

open access: yesAmerican Journal of Obstetrics and Gynecology, 1993
Cyclic neutropenia is characterized by periodic episodes of neutropenia that are often associated with infectious complications. A patient with cyclic neutropenia experienced two pregnancies with an amelioration of her infectious complications and an increase in neutrophil count. Cyclic neutropenia may follow a benign course during pregnancy.
T E, Polcz, R J, Stiller, J C, Whetham
exaly   +4 more sources

Home - About - Disclaimer - Privacy